• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    More On DRREDDY.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Dr. Reddy's Laboratories Ltd. (DRREDDY.NS)

    -NSE
    3,233.25 Down 130.05(3.87%) Jan 30
    Add to Portfolio
    Prev Close:3,363.30
    Open:3,370.00
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:3,201.00 - 3,372.85
    52wk Range:2,246.50 - 3,666.25
    Volume:632,758
    Avg Vol (3m):327,170
    Market Cap:550.83B
    P/E (ttm):25.34
    EPS (ttm):127.62
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):20.85
    P/S (ttm):3.99
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-15) :133.95
    Quarterly EPS Est (Mar-15) :34.68
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.89

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dr. Reddy’s Laboratories Limited operates as an integrated pharmaceutical company in India. It operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback